Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Revenue

Viridian Therapeutics had revenue of $75.00K in the quarter ending June 30, 2025, with 4.17% growth. This brings the company's revenue in the last twelve months to $305.00K, up 5.90% year-over-year. In the year 2024, Viridian Therapeutics had annual revenue of $302.00K, down -3.82%.

• Revenue (ttm): $305.00K
• Revenue Growth: +5.90%
• P/S Ratio: 5,047.00
• Revenue / Employee: $2,133
• Employees: 143
• Market Cap: 1.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	302.00K	-12.00K	-3.82%
Dec 31, 2023	314.00K	-1.46M	-82.28%
Dec 31, 2022	1.77M	-1.19M	-40.20%
Dec 31, 2021	2.96M	1.91M	182.19%
Dec 31, 2020	1.05M	-3.41M	-76.46%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.